NASDAQ$AIXC

AIxCrypto Holdings Inc · Q2 2025 earnings

Q2 2025 earnings · · After market close · Investor relations

Briefing

AIxCrypto reported Q2 2025, net loss of $1.7M.

For Q2 2025, AIxCrypto reported a net loss of $1.7M. Management discusses operating trends, capital, and sector risks in the quarterly filing.

  • Net loss $1.7M.
  • AIxCrypto MD&A highlights liquidity, capital, and core trends.
  • Segment and macro factors shape year-over-year comparisons.

Headline financials

Total Revenue

$0.00

Previous: $0.00
EPS (adj)

-$1.00

Previous: -$10.00+90.0%
Free Cash Flow

-$1.69M

No prior period
Net Income

-$1.69M

Previous: -$1.48M-14.1%
Operating Income

-$1.68M

Previous: -$1.74M+3.3%
Gross Profit

-$368K

Previous: $0.00

Revenue & EPS history

Qualigen · Revenue · Quarterly

$0

Q2 2025
Beat estimate in 4 of 9 quarters(44%)
ActualEstimate

Revenue by segment

Qualigen · $700K total across 1 segment · Q1 2022

  • Product Sales
    $700K-50.0%

Forward guidance

Clinical-stage and small biotech emphasize pipeline milestones and cash runway.

Tailwinds

  • Clinical progress and partnerships.
  • Regulatory pathway optionality.
  • Balance-sheet flexibility.

Headwinds

  • Operating losses and financing needs.
  • Trial and regulatory risk.
  • Commercialization timing uncertain.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2025

Historical avgQ2 2025

-1.6%

Avg return

Earnings day

+0.3%

Avg return

5 days after

-8.3%

Avg return

30 days after

43%

16 / 37 earnings

Positive

+18.8%

Q3 2016

Best reaction

-22.8%

Q2 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025+10.4%-3.7%-13.2%
Q2 2025+6.8%+7.1%+19.0%
Q1 2025+2.0%-7.0%-37.4%
Q3 2024-12.6%-6.3%-6.1%
Q2 2024-1.7%+8.5%-17.5%
Q1 2024+5.7%+68.7%+41.6%
Q4 2023+1.0%-15.9%-29.1%
Q3 2023+4.5%+2.4%-14.7%
Q2 2023+1.0%+2.9%-6.4%
Q1 2023-5.9%-3.8%-5.9%
Q4 2022+0.9%+12.7%+0.8%
Q3 2022-4.5%-3.2%-35.5%
Q2 2022-0.2%-3.5%-23.1%
Q1 2022+5.4%+0.0%+20.8%
Q4 2021-3.2%-5.5%-15.3%
Q3 2021+0.9%-6.1%-9.0%
Q2 2021-22.8%-29.3%-12.0%
Q1 2021+17.6%+20.3%+46.4%
Q4 2020+5.8%+1.2%-17.3%
Q4 2019-14.0%-13.5%+6.9%
Q3 2019-16.6%-25.3%-31.5%
Q2 2019-1.4%+4.1%-64.5%
Q1 2019-2.8%-9.6%-5.1%
Q4 2018+10.0%+9.4%-10.7%
Q3 2018-12.0%-12.2%-17.3%
Q2 2018-2.4%-5.9%-18.5%
Q1 2018+1.1%+13.1%+7.4%
Q4 2017-4.9%+2.7%+9.3%
Q3 2017-7.2%-11.1%-15.3%
Q2 2017-4.4%-6.7%-2.5%
Q1 2017-1.7%-4.7%-8.4%
Q4 2016-11.4%+6.6%-44.6%
Q3 2016+18.8%+25.0%+23.1%
Q2 2016+1.5%-2.3%+4.6%
Q1 2016-2.8%
Q3 2015-4.7%
Q2 2015-13.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro